Hemostats find application in various medical procedures, aiding in achieving effective blood control. They are commonly used in surgeries to stop bleeding and promote wound healing. Key features of hemostats include their ability to quickly form a clot and their biocompatibility. Hemostats are utilized in multiple medical specialties, such as general surgery, orthopedics, cardiovascular surgery, and trauma care. These versatile medical devices play a crucial role in ensuring patient safety and better surgical outcomes by preventing excessive bleeding and reducing the risk of complications.
According to Data Bridge Market Research, the Global Hemostats Market is expected to reach USD 4.65 billion by 2029. The market is expected to grow with a CAGR of 6.85% in the forecast period of 2022 to 2029.
“Increasing number of surgical procedures boosts the market’s growth”
The hemostats market experiences growth due to the increasing number of surgical procedures being performed. As surgical interventions become more common, there is a rising demand for effective hemostatic agents to control bleeding and promote better patient outcomes. Hemostats play a crucial role in various medical specialties, including general surgery, cardiovascular surgery, orthopedics, and obstetrics, contributing to their widespread adoption. The expanding application of hemostats in diverse surgical settings drives market growth as healthcare providers seek reliable and efficient solutions to manage bleeding during procedures.
What restraints the growth of the global hemostats market?
“Scarcity of skilled professionals restraints the market’s growth”
The growth of the hemostats market is limited by a scarcity of skilled professionals proficient in using these medical devices. Proper application and handling of hemostats require specialized training and expertise, which can be scarce in some regions or medical facilities. The lack of skilled professionals may lead to suboptimal utilization of hemostats during surgical procedures, impacting their overall effectiveness and potentially hindering market growth. Efforts to enhance training programs and increase the availability of skilled personnel can help address this restraint and facilitate market expansion.
Segmentation: Global Hemostats Market
The global hemostats market is segmented on the basis of product type, formulation, application, indication, and end-user.
- On the basis of product type, the hemostats market is segmented into thrombin based, combination, oxidized regenerated cellulose based, gelatin based and collagen based hemostat.
- On the basis of formulation, the hemostats market is segmented into matrix & gel hemostats, sheet and pad hemostats, sponge hemostats, and powder hemostats.
- On the basis of application, the hemostats market is segmented into orthopedic, general surgery, neurological surgery, cardiovascular surgery, reconstructive surgery and gynecological surgery.
- On the basis of indication, the hemostats market is segmented into wound closure and surgery.
- On the basis of end-user into hospitals, clinics, ambulatory centers, community healthcare and others.
Regional Insights: Asia-Pacific dominates the Global Hemostats Market
Asia-Pacific dominates the hemostats market due to a surge in surgical procedures, and the demand for hemostatic products has risen significantly. These products play a crucial role in controlling bleeding during surgeries, leading to improved patient outcomes. The increasing need for effective blood management has driven the market expansion of hemostatic products, catering to the growing healthcare demands.
To know more about the study visit, https://www.databridgemarketresearch.com/reports/global-hemostats-market
The Prominent Key Players Operating in the Global Hemostats Market Include:
- CR Bard, Inc. (U.S.)
- B. Braun Melsungen AG (Germany)
- Baxter International, Inc. (U.S.)
- Integra LifeSciences (U.S.)
- Marine Polymer Technologies, Inc. (U.S.)
- Teleflex (U.S.)
- Ethicon, Inc. (U.S.)
- Pfizer, Inc. (U.S.)
- Z-Medica LLC (U.S.)
- Gelita Medical GmbH (Germany)
- Anika Therapeutics, Inc. (U.S.)
- Stryker (U.S.)
- Integra Lifesciences Corporation(U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of global hemostats market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Hemostats Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
